References
- Dubovsky SL, Buzan R. Mood disorders. In: Hales RE, Yudofsky SC, Talbott JA, eds. The American Psychiatric Press textbook of psychiatry. 3rd ed. Washington, DC: American Psychiatric Press, 1999: 479–565
- Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276(4): 293–9
- Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157(6): 924–30
- Wisner KL, Zarin DA, Holmboe ES, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000; 157(12): 1933–40
- Ling FW. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices. J Clin Psychiatry 2000; 61(Suppl 12): 9–16
- The Royal Australian College of Obstetricians and Gynaecologists. Premenstrual syndrome (PMS). Available at: http://www.nevdgp.org.au/geninf/std_misc/PREMENSTRUAL_SYNDROME.htm. Accessed April 8, 2002
- Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 1995; 332(23): 1529–34
- Yonkers KA, Halbreich U, Freeman E, et al. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull 1996; 32(1): 41–6
- Yonkers KA, Gullion C, Williams A, et al. Paroxetine as a treatment for premenstrual dysphoric disorder. J Clin Psychopharmacol 1996; 16(1): 3–8
- Freeman EW, Rickets K, Sondheimer SJ. Fluvoxamine for premenstrual dysphoric disorder: a pilot study. J Clin Psychiatry 1996; 57(Suppl 8): 56–60
- Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998; 179(2): 444–52
- Wisner KL, Gelenberg AJ, Leonard H, et al. Pharmacologic treatment of depression during pregnancy. JAMA 1999; 282(13): 1264–9
- Cohen LS. Update on reproductive safety of psychotropic medications. Curr Affective Illness 2001; 20(5): 5–11
- Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335(14): 1010–5
- Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336(4): 258–62
- Steiner M, Yonkers L. Depression in women. London: Martin Dunitz, 1998: 33–5
- Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 1999; 104(1):e11. Available at: http://www.pediatrics.org/cgi/content/full/104/1/e11. Accessed Apr 9, 2002
- Llewellyn A, Stowe ZN. Psychotropic medications in lactation. J Clin Psychiatry 1998; 59(Suppl 2): 41–52
- Suri RA, Altshuler LL, Burt VK, et al. Managing psychiatric medications in the breast-feeding woman. Medscape Women's Health 1998; 3(1): 1–12
- Stowe ZN, Calhoun K, Ramsey C, et al. Mood disorders during pregnancy and lactation: defining issues of exposure and treatment. CNS Spectrums 2001; 6(2): 150–66
- Cohen LS. Update on reproductive safety of psychotropic medications. Part II. Curr Affective Illness 2001; 20(6): 5–12